Results per Page:
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
Meshinchi’s research training the body to fight cancer is expanding from blood cancers to solid tumors
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
February 27, 2026
Boosting the effectiveness of CAR T-cell therapies against AML
Dr. Erik Kimble wins award from the American Society of Gene & Cell Therapy
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Keep your enemies closer: targeting membrane-proximal domains for improved immunotherapy
From the Walter Lab, Clinical Research Division
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Lyani Valle: leukemia survivor, Obliteride walker
'Cancer was a huge wake-up call to what is important in life'
MERGE improves precision medicine for acute myeloid leukemia
from Dr. Pamela Becker, Clinical Research Division